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The US Surgeon General’s ‘Family History Initiative’, launched in
2004, underlines increasing public and professional awareness of
the importance of knowing the health history of your close
relatives and the benefits this can bring to the health care of family
members. Advances in human genetics have given substance to the
old ‘experiential’ knowledge of health problems that run in families
and the risks of being affected by the same condition. However,
this field is not only the province of medical and biological
research but is also a minefield of ethical concerns, issues for the
wider society, and potential adverse psychological effects on
individual patients and families. There is a fuzzy border between
research and care, with potentially huge cost implications.
Inherited cancer syndromes can well be regarded as an example
of so-called ‘post normal science’ where facts are uncertain, values
in dispute, stakes high, and decisions urgent.
‘Genetic Predisposition to Cancer’ is welcome, for many surveys
show that family and general practitioners and even some
specialists have a serious lack of knowledge in this area. The
editors of this book are among the world leaders in the field of
inherited cancer syndromes and therefore ideally suited to produce
this overview.
After a clear and valuable glossary that might, however, have
merited more discussion of key issues such as the difference
between polymorphism and mutation, the book is divided in five
main parts: Basic principles, Inherited cancer syndromes, Chro-
mosome fragility and Gorlin syndrome, Common cancers, and
Psychological, ethical and organisational issues. All things
considered, this book is, as claimed by the authors, really
comprehensive and nearly exhaustive.
The first part gives a concise and valuable overview, even though
some articles were probably written 2 or 3 years before. The
contribution on genetic linkage and association studies is brilliant
and will certainly be useful for both students and academic staff.
The second part, ‘Inherited cancer syndromes’, deals with
established gene-based syndromes. However, it is not clear why
renal cell carcinoma is included in this part while less-common
cancers such as pancreatic cancer are placed in the fourth part,
‘Common cancers’. The issue of classification is a critical and
difficult. Part two is almost entirely gene-based (RB1, NF1 and
NF2, MEN1, MEN2, TP53, and PTEN) with the exception of the
discussion on renal tumours (both childhood and adulthood),
which is organ-based. An organ-based classification is the main
basis of the fourth part and leads to some redundancy, for
example, with BRCA2, which is quoted in Familial breast cancer,
Familial ovarian cancer, and Familial prostate cancer. However,
despite these minor criticisms, the book is well organised and each
chapter is extensively illustrated with figures, tables, algorithms, or
clinical pictures, many of which are very well chosen and
enlightening. Another very useful feature is the ‘Key Points’
section at the end of each chapter.
This book can be highly recommended for its numerous
strengths, but it does suffer from some imbalance between
biological and clinical discussion. For example, Chapter 26,
Familial Prostate Cancer and its Management, devotes five pages
to an extensive description of segregation analysis, linkage
analysis, and known genes that are potentially involved, before
going on to mention that ‘a hint of linkage from one or more
collections was subsequently not confirmedy’. Elsewhere, the
issue of screening is poorly described, with no mention of the
impact of treatment on quality of life (incontinence and sexual
dysfunction should be set against the expected increase in life
expectancy due to early diagnosis). The lack of discussion of
clinical management may perhaps leave clinicians and practi-
tioners uneasy with what is a really valuable scientific overview.
There is a genetic and biological perspective throughout the book,
exemplified by the use of geneticists’ terminology: ‘gene highly
penetrant’ where an epidemiologist might have written ‘a high
lifetime cumulative risk’ and a clinician something like ‘makes the
occurrence of the disease very likely’. Ethical concerns might have
merited more analysis (in the case of disclosure particularly), but
readers who want more detail will find some interesting references
at the end of that article.
Genetic Predisposition to Cancer is not a book that can be read at
one sitting from cover to cover, but it will be very useful as a
reference; particularly, the first three parts, Basic principles,
Inherited Cancer Syndromes and Chromosome fragility syn-
dromes, and the Gorlin Syndrome. It will be a particularly valuable
reference for students and clinicians who want an overview of this
fast moving field. It can be recommended as the root and branches
of a ‘knowledge tree’ whose leaves (update information) will have
to be found in scientific journals.
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